You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ACITRETIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Acitretin

A generic version of ACITRETIN was approved as acitretin by BARR LABS INC on April 4th, 2013.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ACITRETIN?
  • What are the global sales for ACITRETIN?
  • What is Average Wholesale Price for ACITRETIN?
Summary for ACITRETIN
Drug patent expirations by year for ACITRETIN
Drug Prices for ACITRETIN

See drug prices for ACITRETIN

Recent Clinical Trials for ACITRETIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Translational Immunology InstitutePhase 4
Singapore General HospitalPhase 4
South Valley UniversityPhase 4

See all ACITRETIN clinical trials

Pharmacology for ACITRETIN
Drug ClassRetinoid
Medical Subject Heading (MeSH) Categories for ACITRETIN

US Patents and Regulatory Information for ACITRETIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic ACITRETIN acitretin CAPSULE;ORAL 217774-001 Aug 5, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa ACITRETIN acitretin CAPSULE;ORAL 202897-001 Apr 4, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc ACITRETIN acitretin CAPSULE;ORAL 202552-002 Dec 23, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Barr Labs Inc ACITRETIN acitretin CAPSULE;ORAL 091455-001 Apr 4, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience ACITRETIN acitretin CAPSULE;ORAL 203707-001 Sep 10, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.